Vinati Organics Ltd Q1 FY27 Earnings Analysis

- FY26 growth was similar to FY25, around 5%. - Targeting approximately 15% volume growth at the company level in FY27. - Antioxidants segment delivered 15% revenue growth in FY26 and expected to maintain strong momentum in FY27. - ATBS expected to see 15% volume growth year-on-year for the next 3 years. - Butyl phenols expect moderate growth in FY27. - IB and HP-MTBE expected to achieve double-digit growth in FY27. - IBB volumes declined in FY26 due to raw material unavailability but production and sales are now back on track. - Customized products showed strong 10% year-on-year growth, expected to continue. - Long-term growth planned via organic expansion with INR250-300 crores annual investment for 3-5 years. - Revenue from new products including AO and butyl phenols expected to reach INR800-900 crores in next 2 years.

- FY26 growth was modest at around 5% compared to FY25. - Antioxidants segment expects continued strong momentum and market expansion, supporting growth. - ATBS segment anticipates approximately 15% volume growth year-on-year for the next 3 years. - Butyl phenols segment expects moderate growth supported by improving demand. - IB and HP-MTBE products forecast double-digit growth in FY27. - IBB production and sales have normalized after prior raw material challenges. - Overall company targets approximately 15% volume growth in FY27. - EBITDA margin guidance maintained at 26%-27% for the long term. - Capex of INR 200-250 crores planned for FY27 focused on capacity expansion and new product introductions. - VOPL subsidiary expected to contribute revenues (~INR100-120 crores) starting Q3 FY27 after process reengineering. - Company remains debt-free and funded through internal accruals, indicating strong financial health supporting growth.

- FY26 capex was approximately INR 270 crores, including investments in VOPL for capacity expansion, new product development, and operational scalability. - FY27 capex is earmarked at around INR 200-250 crores focusing on capacity expansion, innovation, and operational efficiency. - Major portion (~INR 200 crores) of FY27 capex will be through the main holding company Vinati Organics Limited; INR 40-50 crores through subsidiary VOPL. - The ATBS capacity expansion completed, with further utilization expected from FY28 onwards. - Process reengineering at VOPL expected to be completed by September 2026; revenue contribution from Q3 FY27. - New products under R&D targeting niche chemicals for industries such as food additives, fragrance, personal care, antioxidants, and plastics. - Investment plans continue to be financed through internal accruals; the company remains debt-free with treasury of ~INR 190 crores as of March 31, 2026.

- Vinati Saraf Mutreja stated the company is focusing on organic expansion with a pipeline of products and plans to invest INR250-300 crores annually for the next 3 to 5 years. - The company has been achieving all expansion goals through internal accruals and remains debt-free. - There is no mention of plans for raising new funds through equity or debt in the transcript. - The management confirmed that they will continue the policy of no debt going forward. - The company has a treasury of approximately INR190 crores as of March 31, 2026, supporting their financial stability without external financing.

- No explicit mention of a current or expected order book or pending orders was made in the transcript. - For ATBS, capacity utilization is about 75-80%, indicating healthy demand, but no specific backlog figures were shared. - Management indicated stable industry growth with expectations of approximately 15% volume growth in FY27. - No direct references to order backlog numbers or pending orders were given during the Q&A. - The company is focusing on organic expansion with planned capex of INR250-300 crores annually for product development and capacity enhancement. - Process reengineering for certain products in the subsidiary VOPL is expected to end by September, with revenue starting from Q3 FY27. - Management highlighted stable raw material availability and logistics, supporting uninterrupted fulfillment of orders.